Abstract:Tau, an intrinsically disordered neuronal protein and polyampholyte with an overall positive charge, is a microtubule (MT) associated protein, which binds to anionic domains of MTs and suppresses their dynamic instability. Aberrant tau-MT interactions are implicated in Alzheimer's and other neurodegenerative diseases. Here, we studied the interactions between full length human protein tau and other negatively charged binding substrates, as revealed by differential- interference-contrast (DIC) and fluorescence microscopy. As a binding substrate, we chose anionic liposomes (ALs) containing either 1,2-dioleoyl-sn-glycero-3-phosphatidylserine (DOPS, -1e) or 1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol (DOPG, -1e) mixed with zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) to mimic anionic plasma membranes of axons where tau resides. At low salt concentrations (0 to 10 mM KCl or NaCl) with minimal charge screening, reaction mixtures of tau and ALs resulted in the formation of distinct states of AL-tau complexes coexisting with liquid-liquid phase separated tau self-coacervates arising from the polyampholytic nature of tau containing cationic and anionic domains. AL-tau complexes exhibited distinct types of morphologies. This included, large ≈20-30 micron tau-decorated giant vesicles with additional smaller liposomes with bound tau attached to the giant vesicles, and tau- mediated finite-size assemblies of small liposomes. As the ionic strength of the solution was increased to near and above physiological salt concentrations for 1:1 electrolytes (≈150 mM), AL-tau complexes remained stable while tau self-coacervate droplets were found to dissolve indicative of breaking of (anionic/cationic) electrostatic bonds between tau chains due to increased charge screening. The findings are consistent with the hypothesis that distinct cationic domains of tau may interact with anionic lipid domains of the lumen facing monolayer of the axon plasma membrane suggesting the possibility of transient yet robust interactions at physiologically relevant ionic strengths.

Tannic acid as a biphasic modulator of tau protein liquid-liquid phase separation

Biphasic modulation of tau liquid-liquid phase separation by polyphenols

Liquid − liquid phase separation of tau: Driving forces, regulation, and biological implications

Formation of Tannic Acid-Binding Ovalbumin Amyloid Fibril Hydrogels: Enhanced Antibacterial and Antioxidant Properties

Liquid-liquid phase separation of tau driven by hydrophobic interaction facilitates fibrillization of tau

Inhibitory Effect and Mechanism of Tannic Acid Against Two Starch Digestive Enzymes

Liquid–liquid phase separation in Alzheimer's disease

New Strategy for Reducing Tau Aggregation Cytologically by A Hairpinlike Molecular Inhibitor, Tannic Acid Encapsulated in Liposome

Liquid-Liquid Phase Separation of Tau Protein is Encoded at the Monomeric Level

Cyclic dipeptide-based small molecules modulate zinc-mediated liquid-liquid phase separation of tau

Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease

Thonningianin A from Penthorum chinense Pursh as a targeted inhibitor of Alzheimer's disease‐related β‐amyloid and Tau proteins

Conformational Expansion of Tau in Condensates Promotes Irreversible Aggregation.

Tannic acid inhibits lipopolysaccharide-induced cognitive impairment in adult mice by targeting multiple pathological features

Mixtures of Intrinsically Disordered Neuronal Protein Tau and Anionic Liposomes Reveal Distinct Anionic Liposome-Tau Complexes Coexisting with Tau Liquid-Liquid Phase Separated Coacervates

Tau liquid–liquid phase separation: At the crossroads of tau physiology and tauopathy

Tau protein liquid–liquid phase separation can initiate tau aggregation

TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau

Liquid-liquid phase separation induces pathogenic tau conformations in vitro

Myricetin slows liquid–liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity

A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease.